Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

NCT06860958 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Fluoxetine
DRUG: Roflumilast
DRUG: Placebo

Sponsor

Tanta University